1. Home
  2. NSYS vs GANX Comparison

NSYS vs GANX Comparison

Compare NSYS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSYS
  • GANX
  • Stock Information
  • Founded
  • NSYS 1981
  • GANX 2017
  • Country
  • NSYS United States
  • GANX United States
  • Employees
  • NSYS N/A
  • GANX N/A
  • Industry
  • NSYS Industrial Machinery/Components
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSYS Technology
  • GANX Health Care
  • Exchange
  • NSYS Nasdaq
  • GANX Nasdaq
  • Market Cap
  • NSYS 36.5M
  • GANX 31.5M
  • IPO Year
  • NSYS N/A
  • GANX 2021
  • Fundamental
  • Price
  • NSYS $15.00
  • GANX $1.12
  • Analyst Decision
  • NSYS
  • GANX Strong Buy
  • Analyst Count
  • NSYS 0
  • GANX 4
  • Target Price
  • NSYS N/A
  • GANX $8.25
  • AVG Volume (30 Days)
  • NSYS 9.4K
  • GANX 310.2K
  • Earning Date
  • NSYS 08-07-2024
  • GANX 08-08-2024
  • Dividend Yield
  • NSYS N/A
  • GANX N/A
  • EPS Growth
  • NSYS 173.86
  • GANX N/A
  • EPS
  • NSYS 2.41
  • GANX N/A
  • Revenue
  • NSYS $138,659,000.00
  • GANX N/A
  • Revenue This Year
  • NSYS N/A
  • GANX $1,009.10
  • Revenue Next Year
  • NSYS N/A
  • GANX N/A
  • P/E Ratio
  • NSYS $6.03
  • GANX N/A
  • Revenue Growth
  • NSYS 0.26
  • GANX N/A
  • 52 Week Low
  • NSYS $7.45
  • GANX $1.07
  • 52 Week High
  • NSYS $19.15
  • GANX $5.33
  • Technical
  • Relative Strength Index (RSI)
  • NSYS 65.56
  • GANX 33.74
  • Support Level
  • NSYS $14.05
  • GANX $1.22
  • Resistance Level
  • NSYS $15.00
  • GANX $1.24
  • Average True Range (ATR)
  • NSYS 0.72
  • GANX 0.08
  • MACD
  • NSYS 0.14
  • GANX 0.04
  • Stochastic Oscillator
  • NSYS 95.00
  • GANX 20.00

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: